drugset / Trial / NCT00474409
A Study To Evaluate The Efficacy And Safety Of Betahistine Mesilate In The Treatment Of Patients With Vertigo Caused By Cerebral Infarction In Posterior Circulation
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine the efficacy and safety of Betahistine Mesilate in the treatment of patients with vertigo caused by Cerebral Infarction in posterior circulation.
Timeline
- Start
- 2007-05
- Primary completion
- —
- Completion
- —
Outcome
Outcome not reported
Stopped (Enrollment): “Due to poor enrollment, this study was withdrawn/ terminated.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BETAHISTINE MESILATE | Unknown | — | — |